Dispute Between Treace Medical and Fusion Orthopedics Resolved
03 Mar 2023
Patent Infringement
Preview
Source: Business Wire
Preview
Source: Business Wire
MESA, Ariz.--(BUSINESS WIRE)--Treace Medical Concepts, Inc. (NASDAQ: TMCI) (“Treace Medical”) and Fusion Orthopedics, LLC (“Fusion Orthopedics”) jointly announce that they have reached an amicable resolution of the litigation between the parties.
Treace Medical filed the lawsuit on March 29, 2022 against Fusion Orthopedics in the United States District Court for the District of Arizona, Civil Action No. 2:22- cv-00490, alleging patent, trademark, and copyright infringement, as well as various unfair trade practices based on Fusion Orthopedics’ use, sale, and promotion of the Lapilock 4D Advanced Bunion Surgery, including false advertising and unfair competition.
Fusion Orthopedics subsequently filed counterclaims against Treace Medical, requesting declaratory judgment of non-infringement and invalidity of the patents, declaratory judgment of invalidity of Treace Medical’s LAPIPLASTY trademark, as well as various unfair trade practices based on Treace Medical’s use, sale, and promotion of the Lapiplasty 3D Bunion Correction, including counterclaims of false descriptions and false advertising.
In March 2023, the parties entered into an agreement to settle this matter. While the terms of the settlement are confidential, Fusion Orthopedics is pleased with the outcome.
About Fusion Orthopedics
Fusion Orthopedics (www.fusionorthopedics.com) is a medical device company established in 2014 and known for numerous innovative technologies in the foot and ankle orthopedic market.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.